Browsing by Author "Molina, Jean-Michel"
Now showing items 1-19 of 19
-
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
Castro, Nathalie de et al. | Date Issued: 2022 -
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
Clotet, Bonaventura et al. | Date Issued: 2007 -
Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials
Katlama, Christine et al. | Date Issued: 2010 -
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Katlama, Christine et al. | Date Issued: 2009 -
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
Kozal, Michael et al. | Date Issued: 2020 -
Immunocompromised patients have been neglected in COVID-19 trials: a call for action
Trøseid, Marius et al. | Date Issued: 2022 -
Immunocompromised patients have been neglected in COVID-19 trials: a call for action
Trøseid, Marius et al. | Date Issued: 2022 -
Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
Delagreverie, Héloïse M. et al. | Date Issued: 2020 -
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial
Coelho, Lara E. et al. | Date Issued: 2024 -
Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy
Taburet, Anne-Marie et al. | Date Issued: 2015 -
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
Molina, Jean-Michel et al. | Date Issued: 2011 -
Safety and efficacy of Darunavir (TMC114) with low-dose Ritonavir in treatment-experienced patients: 24-week results of POWER 3
Molina, Jean-Michel et al. | Date Issued: 2007 -
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Lataillade, Max et al. | Date Issued: 2020 -
Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries
Castro, Nathalie De et al. | Date Issued: 2023 -
Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
Cahn, Pedro et al. | Date Issued: 2011